Incyte Corporation

Healthcare · Biotechnology

124.60$ -1.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Incyte Corporation (INCY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 6,958 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INCY
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	67	193	230	222	887	706	552	380	517	374	354	276	232	712	490	329	330	630	830	1,007	1,639	2,303	2,646	3,427	3,561	4,933	5,841	6,782	5,444	6,958
Current Assets	43	143	131	110	648	591	459	311	481	354	328	264	205	656	455	278	310	556	699	867	994	1,505	1,856	2,537	2,360	3,119	4,093	4,645	3,239	5,024
Cash	7.6	51	50	32	110	43	23	30	132	11	19	109	179	450	418	278	224	471	452	521	652	900	1,164	1,833	1,513	2,057	2,951	3,213	1,688	3,098
Cash & Short-Term Investments	7.6	51	50	67	582	508	429	294	470	345	319	256	198	470	424	278	228	509	600	708	809	1,170	1,438	2,118	1,801	2,348	3,239	3,656	2,158	3,581
Receivables	2.5	20	14	27	35	54	8.5	5.2	2.1	1.4	2.1	1.6	1.1	164	5.7	6.4	71	35	58	114	149	266	308	309	482	616	645	744	853	1,024
Inventory	–	–	–	–	–	–	–	–	7.1	–	–	–	–	–	–	3.5	0.3	0.4	0.4	1.8	4.1	6.5	10	17	16	28	42	63	59	101
Property, Plant & Equipment	–	–	–	–	99	48	32	27	10.0	7.7	5.9	3.9	2.8	1.8	4.8	6.4	6.3	27	82	86	168	260	320	378	560	724	739	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	0.0	0.0	0.0	0.0	156	156	156	156	156	156	156	156	156	133
Intangible Assets	–	–	17	15	83	2.9	26	25	14	11	8.7	0.4	4.3	14	10	8.2	6.1	35	16	0.0	270	237	215	194	172	151	129	124	114	117
Total Liabilities	22	53	51	52	264	265	250	225	438	394	439	435	453	815	578	556	505	823	878	836	1,219	672	720	828	950	1,163	1,471	1,592	1,997	1,803
Current Liabilities	21	52	50	52	76	86	78	42	31	28	49	37	50	133	114	298	136	108	221	836	1,219	375	415	500	631	854	1,157	1,240	1,642	1,515
Short-Term Debt	0.1	–	–	–	–	12	21	–	19	18	16	23	29	–	–	298	–	–	85	620	651	7.4	19	28	15	13	11	9.1	10	10
Accounts Payable	4.7	5.8	8.2	6.5	17	7.3	9.1	6.5	2.3	3.6	5.9	7.8	16	21	11	15	14	19	24	30	76	68	104	84	99	172	278	110	197	210
Long-Term Debt	–	–	–	–	188	179	172	168	379	342	371	387	396	443	293	316	331	662	603	620	651	17	17	18	–	32	30	29	34	–
Shareholders' Equity	45	146	180	170	623	440	302	154	79	-19	-85	-160	-221	-102	-89	-227	-175	-193	-82	171	419	1,631	1,926	2,598	2,611	3,770	4,370	5,190	3,448	5,167
Retained Earnings	-37	-26	-28	-55	-85	-268	-405	-571	-736	-839	-914	-1,000	-1,179	-1,391	-1,423	-1,610	-1,654	-1,737	-1,786	-1,779	-1,675	-1,990	-1,878	-1,431	-1,726	-778	-437	160	-1,073	214
Shares Outstanding	40	53	58	56	63	66	67	71	75	83	84	84	90	103	122	125	130	148	168	187	194	205	216	218	218	222	224	226	211	201

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings